Financial Performance - Net sales decreased by 1% to $2,113.3 million[5] - Comparable net sales increased by 2%[2] - Adjusted earnings per share decreased by 22% to $1.90[2, 5] - Free cash flow was ($94.9) million, a decrease compared to $49.2 million in the prior year[2] - Adjusted gross profit decreased by 11% to $743.2 million[5] - Adjusted operating income decreased by 17% to $370.3 million[5] Segment Performance - U S Retail Coffee net sales increased by 15% to $717.2 million[14] - Sweet Baked Snacks net sales decreased by 24% to $253.2 million[14] - International and Away From Home net sales increased by 7% to $290.2 million[14] Fiscal Year 2026 Outlook - The company updated its full-year fiscal 2026 financial outlook[3] - Net sales are expected to increase by 3% to 5%[16] - Free cash flow is projected to be $975 million[16]

Q2 2025 Financial Performance - Net sales increased by 7% year-over-year to $1208560 thousand[108] - Americas net sales increased by 8% year-over-year[66, 68] - EMEA net sales decreased by 1% year-over-year[66, 68] - APAC net sales increased by 12% year-over-year[66, 68] - Abercrombie brands net sales decreased by 5% year-over-year[71] - Hollister brands net sales increased by 19% year-over-year[71] - Operating income was $206658 thousand, representing 171% of net sales[108] - Net income per diluted share was $291[66] Fiscal Year 2025 Outlook - Net sales are expected to grow in the range of 5% to 7%[82] - Operating margin is projected to be in the range of 130% to 135%[82] Share Repurchases - The company has approximately $11 billion remaining under its current share repurchase authorization[95]

Financial Performance & Strategic Focus - Photronics' revenue for the trailing twelve months reached $856 million[12] - The company's operating income for the same period was $212 million[12] - Operating cash flow totaled $228 million[12] - The company's market capitalization stood at $1.21 billion as of August 21, 2025[12] - Q3 2025 revenue was $210.4 million with a gross margin of 33.7% and an operating margin of 22.9%[60] - Non-GAAP diluted EPS for Q3 2025 was $0.51[60] - The company repurchased 1.18 million shares for $20.7 million in Q3 2025[61] Market Position & Growth Drivers - High-end products accounted for 36% of IC revenue and 85% of FPD revenue in Q3 2025[63, 64] - The company anticipates capital expenditures of approximately $200 million in fiscal year 2025[68, 69, 72] - Revenue by geographic origin: Taiwan 34%, China 26%, Korea 19%, US 17%, Europe 4%[12]

Financial Performance - Hafnia reported a TCE income of USD 231.2 million for Q2 2025, with USD 449.9 million for 1H 2025[15] - Adjusted EBITDA for Q2 2025 was USD 134.2 million, and USD 259.3 million for 1H 2025[15] - Net profit for Q2 2025 reached USD 75.3 million (USD 0.15 per share), and USD 138.5 million (USD 0.28 per share) for 1H 2025[15] - A dividend of USD 60.3 million was declared, representing 80% of the net profit, which equals USD 0.1210 per share[15, 26] Fleet and Coverage - As of August 15, 2025, 75% of the fleet's earning days for Q3 2025 were covered at USD 25,395 per day[18] - Net Asset Value (NAV) is approximately USD 3.3 billion, equivalent to around USD 6.55 or NOK 66.07 per share[20] Market Dynamics - Cargo volumes for CPPs and chemicals have increased since 2020, with tonne-miles reaching their highest levels in eight years[38] - The company anticipates that the recent OPEC+ decision to boost production in September will support crude tanker rates and benefit the product tanker market[38] Strategic Initiatives - Hafnia concluded a USD 715 million revolving credit facility on July 10, 2025[18, 77] - The company maintains a strong balance sheet with a Net LTV of 24.1%[25, 76] Supply Outlook - UK, UN, and OFAC have sanctioned more than 400 tankers in 2025, reflecting a total of approximately 800 vessels trading outside normal market competition[55]

FISCAL FOURTH QUARTER & 2025 RESULTS 1 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. Forward- looking statements generally relate to future events and include, without limitation, projections, forecasts and estimates about possible or assumed future results of the Company's business, financial condition, liquidity, results of operations, plans and objectives. In ...

Financial Performance - Royal Bank of Canada's reported NIAT increased by 21% YoY[9] - Adjusted PPPT grew by 25% YoY[9] - Diluted EPS increased by 21% YoY to $3.75, and adjusted diluted EPS increased by 18% YoY to $3.84[9, 17] - All-bank operating leverage was 8.7%, and the all-bank efficiency ratio was 54.4%[9] - Premium ROE was 17.3% (16.1% YTD), and adjusted ROE was 17.7% (16.5% YTD)[9] Segment Performance - Personal Banking net income increased by 22% YoY to $1.938 billion[9, 17] - Commercial Banking net income increased by 2% YoY to $836 million[9, 17] - Capital Markets revenue reached a record $3.8 billion[9, 48] - Wealth Management client assets experienced YoY growth of 12%[9] Capital and Risk Management - The CET1 ratio stood at 13.2%[9, 21] - Share buybacks amounted to 5.4 million shares for $955 million[9, 21] - ACL to loans ratio was 74 bps[9, 63]

® BioXcel Therapeutics | 555 Long Wharf Drive, 12th Floor | New Haven, CT 06511 | www.bioxceltherapeutics.com Agitation Associated with Bipolar Disorders or Schizophrenia in the At-Home Setting SERENITY At-Home Pivotal Phase 3 Safety Trial Topline Results August 27, 2025 Nasdaq: BTAI Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe ...

Financial Performance - Net sales increased by 18% to $2,125.1 million in FY25 Q1[1] - Comparable net sales increased by 1%[1] - Adjusted earnings per share increased by 10% to $2.44[1] - Free cash flow was $49.2 million, compared to $67.6 million in the prior year[1] - Adjusted Gross Profit increased 29% to $832.5 million[1] - Adjusted Operating Income increased 35% to $447.9 million[1] Segment Results - U S Retail Coffee net sales were $623.4 million, with no change YoY[8] - U S Retail FH&S net sales were $496.8 million, up 7% YoY[8] - U S Retail Pet Foods net sales were $399.7 million, down 9% YoY[8] - International & AFH net sales decreased 1% to $271.5 million[8] Full Year Fiscal 2025 Outlook - Net sales are expected to increase 8.5% to 9.5%[9] - Adjusted EPS is projected to be $9.60 to $10.00[9] - Free cash flow is estimated at $875 million[9]

Acquisition of OrganOx ~Expanding transplant opportunities for waiting patients globally and contributing to the development of transplant medicine~ Terumo Corporation Chief Executive Officer Hikaru Samejima August 27, 2025 Acquisition Overview | Target Company | OrganOx Limited | | --- | --- | | Acquisition Price | $1.5B（cash free / debt free basis） | | Transaction | Acquisition of 100% of OrganOx's outstanding shares in cash consideration | | Structure | | | Signing Date | August 23, 2025 | | | *Closing i ...

Financial Performance - The company's portfolio grew to CHF 2.1 billion[10] - Rental income increased by 38%[10] - Revaluations resulted in gains of CHF 71 million[10] - EBIT reached CHF 95.7 million[10] - NAV per share excluding deferred taxes was CHF 121.69[10] - Gross rental income was CHF 81.3 million[47] Market Trends in Lake Geneva Region - Vacancy rates remain low due to construction lagging behind demand[14] - Strong demand is fueled by demographic trends and immigration[14] - Rental growth is projected to continue, especially in Geneva[14] - Vacancy rates in Vaud and Geneva are declining, standing at 0.89% and 0.34% respectively in Q2 2025[28] Portfolio and Strategy - The property portfolio is valued at CHF 2,124 million, comprising 203 buildings and 3,043 residential units[52] - The company aims for a 1-2% yearly like-for-like rental growth[50]